CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan OrthoPediatrics Corp. - KIDS CFD

42.59
0.07%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.17
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 42.62
Open* 42.19
1-Year Change* -18.91%
Day's Range* 42.05 - 42.72
52 wk Range 35.67-60.75
Average Volume (10 days) 99.96K
Average Volume (3 months) 2.61M
Market Cap 982.28M
P/E Ratio 8,772.07
Shares Outstanding 22.99M
Revenue 122.29M
EPS 0.00
Dividend (Yield %) N/A
Beta 0.89
Next Earnings Date May 2, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 29, 2023 42.59 0.75 1.79% 41.84 42.90 41.84
Mar 28, 2023 42.62 1.16 2.80% 41.46 42.65 40.62
Mar 27, 2023 41.77 1.80 4.50% 39.97 42.14 39.97
Mar 24, 2023 41.72 1.34 3.32% 40.38 42.01 40.00
Mar 23, 2023 41.29 1.60 4.03% 39.69 42.34 39.69
Mar 22, 2023 41.04 -1.00 -2.38% 42.04 42.98 41.00
Mar 21, 2023 42.95 0.74 1.75% 42.21 43.20 42.18
Mar 20, 2023 41.95 0.50 1.21% 41.45 42.91 40.83
Mar 17, 2023 42.47 1.34 3.26% 41.13 43.14 41.13
Mar 16, 2023 41.99 0.78 1.89% 41.21 42.49 39.56
Mar 15, 2023 41.41 2.21 5.64% 39.20 41.47 38.20
Mar 14, 2023 40.59 -1.39 -3.31% 41.98 41.98 38.96
Mar 13, 2023 39.63 0.46 1.17% 39.17 40.54 37.24
Mar 10, 2023 39.57 0.74 1.91% 38.83 40.16 38.54
Mar 9, 2023 40.20 -0.81 -1.98% 41.01 41.99 40.03
Mar 8, 2023 41.41 -0.85 -2.01% 42.26 43.19 41.29
Mar 7, 2023 42.98 -0.23 -0.53% 43.21 43.91 42.17
Mar 6, 2023 43.97 -0.02 -0.05% 43.99 44.88 42.83
Mar 3, 2023 44.76 1.85 4.31% 42.91 44.86 41.47
Mar 2, 2023 43.20 0.39 0.91% 42.81 44.56 42.32

OrthoPediatrics Corp. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 122.289 98.049 71.078 72.552 57.559
Revenue 122.289 98.049 71.078 72.552 57.559
Cost of Revenue, Total 31.629 24.646 16.047 17.933 14.879
Gross Profit 90.66 73.403 55.031 54.619 42.68
Total Operating Expense 147.688 116.073 97.833 81.629 67.112
Selling/General/Admin. Expenses, Total 96.933 79.275 64.529 57.211 44.987
Research & Development 8.014 5.543 5.273 5.748 4.732
Unusual Expense (Income) 3.991 0.461 7.324 0.737 0
Operating Income -25.399 -18.024 -26.755 -9.077 -9.553
Interest Income (Expense), Net Non-Operating 23.506 -0.447 -6.932 -3.538 -2.255
Other, Net -1.796 1.083 0.02 -0.07 -0.217
Net Income Before Taxes -3.689 -17.388 -33.667 -12.685 -12.025
Net Income After Taxes 1.258 -16.26 -32.944 -12.685 -12.025
Net Income Before Extra. Items 1.258 -16.26 -32.944 -12.685 -12.025
Total Extraordinary Items 0 0 -1.046
Net Income 1.258 -16.26 -32.944 -13.731 -12.025
Total Adjustments to Net Income 0
Income Available to Common Excl. Extra. Items 1.258 -16.26 -32.944 -12.685 -12.025
Income Available to Common Incl. Extra. Items 1.258 -16.26 -32.944 -13.731 -12.025
Dilution Adjustment
Diluted Net Income 1.258 -16.26 -32.944 -13.731 -12.025
Diluted Weighted Average Shares 20.9477 19.2683 18.0568 14.6242 12.5674
Diluted EPS Excluding Extraordinary Items 0.06005 -0.84388 -1.82446 -0.8674 -0.95684
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS 0.18389 -0.82832 -1.56082 -0.817 -0.95684
Depreciation / Amortization 7.121 6.148 4.66 2.514
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total revenue 30.994 34.95 32.928 23.417 24.813
Revenue 30.994 34.95 32.928 23.417 24.813
Cost of Revenue, Total 9.77 9.061 7.947 4.851 6.732
Gross Profit 21.224 25.889 24.981 18.566 18.081
Total Operating Expense 39.303 41.911 36.671 29.803 30.374
Selling/General/Admin. Expenses, Total 27.498 27.035 26.977 22.925 21.573
Research & Development 2.034 2.206 1.747 2.027 1.608
Unusual Expense (Income) 0.001 3.609 0.461
Operating Income -8.309 -6.961 -3.743 -6.386 -5.561
Interest Income (Expense), Net Non-Operating 0.541 22.302 3.798 -3.136 5.114
Other, Net -0.128 -0.945 -0.827 0.105 0.281
Net Income Before Taxes -7.896 14.396 -0.772 -9.417 -0.166
Net Income After Taxes -7.848 18.539 -0.333 -9.1 0.072
Net Income Before Extra. Items -7.848 18.539 -0.333 -9.1 0.072
Net Income -7.848 18.539 -0.333 -9.1 0.072
Income Available to Common Excl. Extra. Items -7.848 18.539 -0.333 -9.1 0.072
Income Available to Common Incl. Extra. Items -7.848 18.539 -0.333 -9.1 0.072
Diluted Net Income -7.848 18.539 -0.333 -9.1 0.072
Diluted Weighted Average Shares 20.7066 21.2953 19.7923 19.3669 19.3046
Diluted EPS Excluding Extraordinary Items -0.37901 0.87057 -0.01682 -0.46987 0.00373
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.37898 0.98072 -0.01682 -0.46987 0.01925
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 133.648 158.429 128.058 97.156 69.561
Cash and Short Term Investments 53.543 83.899 70.777 60.691 42.582
Cash 7.641 28.758 70.777 60.691 42.582
Total Receivables, Net 17.942 17.549 16.567 9.501 5.603
Accounts Receivable - Trade, Net 17.942 17.212 16.003 8.999 5.603
Total Inventory 57.569 52.989 38 25.708 20.545
Prepaid Expenses 3.229 2.618 1.464 1.256 0.831
Total Assets 304.274 320.412 182.154 112.105 82.301
Property/Plant/Equipment, Total - Net 28.515 27.227 21.349 12.768 10.391
Property/Plant/Equipment, Total - Gross 51.604 44.878 22.635 18.334
Accumulated Depreciation, Total -23.089 -17.651 -9.867 -7.943
Intangibles, Net 69.762 64.245 18.974 2.181 2.349
Total Current Liabilities 29.715 35.028 13.663 9.217 9.467
Accounts Payable 9.325 10.038 6.467 3.971 5.495
Accrued Expenses 5.351 10.882 4.349 3.552 2.905
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.137 0.131 0.124 0.118 0.113
Other Current Liabilities, Total 14.902 13.977 2.723 1.576 0.954
Total Liabilities 78.905 85.644 39.793 30.373 34.806
Total Long Term Debt 0.907 1.044 26.067 21.156 25.339
Long Term Debt 0.907 1.044 26.067 21.156 25.339
Total Equity 225.369 234.768 142.361 81.732 47.495
Redeemable Preferred Stock 0
Common Stock 0.005 0.005 0.004 0.004 0.002
Additional Paid-In Capital 394.899 388.622 271.182 197.442 150.424
Retained Earnings (Accumulated Deficit) -178.026 -161.766 -128.822 -115.091 -103.066
Other Equity, Total 8.491 7.907 -0.003 -0.623 0.135
Total Liabilities & Shareholders’ Equity 304.274 320.412 182.154 112.105 82.301
Total Common Shares Outstanding 19.6772 19.5603 16.7231 14.5382 12.6218
Other Current Assets, Total 1.365 1.374 1.25
Goodwill, Net 72.349 70.511 13.773
Other Liabilities, Total 43.512 43.817 0.063
Treasury Stock - Common 0
Cash & Equivalents 45.902 55.141
Deferred Income Tax 4.771 5.755
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 131.424 133.648 135.459 145.388 152.028
Cash and Short Term Investments 45.025 53.543 57.683 65.853 76.635
Cash 17.957 7.641 6.334 10.565 21.426
Cash & Equivalents 27.068 45.902 51.349 55.288 55.209
Total Receivables, Net 17.911 17.942 18.205 19.317 16.874
Accounts Receivable - Trade, Net 17.911 17.942 18.146 19.222 16.551
Total Inventory 64.077 57.569 55.458 56.376 55.266
Prepaid Expenses 3.048 3.229 2.745 2.471 1.884
Other Current Assets, Total 1.363 1.365 1.368 1.371 1.369
Total Assets 300.995 304.274 303.593 307.655 313.352
Property/Plant/Equipment, Total - Net 31.068 28.515 28.783 28.242 28.342
Goodwill, Net 70.987 72.349 70.49 69.656 68.463
Intangibles, Net 67.516 69.762 68.861 64.369 64.519
Total Current Liabilities 34.333 29.715 28.018 30.329 36.623
Accounts Payable 14.578 9.325 8.972 10.142 12.009
Accrued Expenses 4.433 5.351 4.655 5.651 10.1
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.139 0.137 0.136 0.134 0.132
Other Current Liabilities, Total 15.183 14.902 14.255 14.402 14.382
Total Liabilities 85.951 78.905 82.475 86.054 91.207
Total Long Term Debt 0.872 0.907 0.942 0.977 1.011
Long Term Debt 0.872 0.907 0.942 0.977 1.011
Deferred Income Tax 4.335 4.771 4.848 5.06 5.233
Other Liabilities, Total 46.411 43.512 48.667 49.688 48.34
Total Equity 215.044 225.369 221.118 221.601 222.145
Common Stock 0.005 0.005 0.005 0.005 0.005
Additional Paid-In Capital 396.425 394.899 392.929 391.415 390
Retained Earnings (Accumulated Deficit) -187.126 -178.026 -178.098 -175.901 -172.145
Other Equity, Total 5.74 8.491 6.282 6.082 4.285
Total Liabilities & Shareholders’ Equity 300.995 304.274 303.593 307.655 313.352
Total Common Shares Outstanding 19.8213 19.6772 19.6722 19.67 19.6594
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -16.26 -32.944 -13.731 -12.025 -8.932
Cash From Operating Activities -13.063 -18.53 -17.769 -15.583 -7.217
Cash From Operating Activities 10.68 8.01 4.671 2.892 2.405
Non-Cash Items 6.196 12.113 2.669 3.185 3.478
Cash Interest Paid 0.056 1.233 4.229 2.255 2.49
Changes in Working Capital -12.551 -4.986 -11.378 -9.635 -4.168
Cash From Investing Activities -7.411 -69.693 -61.922 -5.965 -6.544
Capital Expenditures -16.011 -11.3 -12.086 -5.463 -6.544
Other Investing Cash Flow Items, Total 8.6 -58.393 -49.836 -0.502 0
Cash From Financing Activities 0.006 46.732 91.019 39.657 54.734
Financing Cash Flow Items 0 0 -0.99
Issuance (Retirement) of Stock, Net 0.137 71.857 61.137 43.835 53.775
Issuance (Retirement) of Debt, Net -0.131 -25.125 29.882 -4.178 7.914
Foreign Exchange Effects -0.658 -0.404 0.008
Net Change in Cash -21.126 -41.895 11.336 18.109 40.973
Total Cash Dividends Paid 0 0 -5.965
Deferred Taxes -1.128 -0.723
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -9.1 -16.26 -16.332 -14.135 -10.379
Cash From Operating Activities -4.197 -13.063 -11.828 -10.891 -1.915
Cash From Operating Activities 2.961 10.68 7.87 5.147 2.539
Deferred Taxes -0.317 -1.128 -0.89 -0.602 -0.312
Non-Cash Items 4.549 6.196 9.581 9.083 6.11
Cash Interest Paid 0.013 0.056 0.043 0.029 0.015
Changes in Working Capital -2.29 -12.551 -12.057 -10.384 0.127
Cash From Investing Activities 14.303 -7.411 -10.376 -7.332 -5.607
Capital Expenditures -4.197 -16.011 -14.376 -7.332 -5.607
Other Investing Cash Flow Items, Total 18.5 8.6 4 0 0
Cash From Financing Activities -0.033 0.006 0.04 -0.002 0.03
Issuance (Retirement) of Stock, Net 0 0.137 0.137 0.062 0.062
Issuance (Retirement) of Debt, Net -0.033 -0.131 -0.097 -0.064 -0.032
Foreign Exchange Effects 0.241 -0.658 -0.266 0.029 0.155
Net Change in Cash 10.314 -21.126 -22.43 -18.196 -7.337
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Squadron Capital LLC Corporation 30.0162 6901764 1525000 2022-09-20 LOW
Brown Capital Management, LLC Investment Advisor 13.8126 3175993 -205041 2022-12-31 LOW
Brown Advisory Investment Advisor/Hedge Fund 6.897 1585854 18238 2022-12-31 LOW
Riverbridge Partners, LLC Investment Advisor 4.611 1060238 -53264 2022-12-31 LOW
Braidwell LP Hedge Fund 4.5435 1044699 1044699 2022-12-31
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.101 942959 83752 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.4557 794591 8351 2022-12-31 LOW
Next Century Growth Investors, LLC Investment Advisor 2.4321 559222 12762 2022-12-31 MED
Granahan Investment Management, Inc. Investment Advisor 2.2069 507432 128239 2022-12-31 LOW
New York State Common Retirement Fund Pension Fund 2.0359 468116 29205 2022-12-31 LOW
AWM Investment Company, Inc. Investment Advisor/Hedge Fund 1.7207 395658 50183 2022-12-31 LOW
Wasatch Global Investors Inc Investment Advisor/Hedge Fund 1.6793 386135 243 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.6321 375273 15426 2022-12-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.5458 355441 28035 2022-12-31 LOW
D. F. Dent & Company, Inc. Investment Advisor 1.3965 321103 -79936 2022-12-31 LOW
First Light Asset Management, LLC Investment Advisor/Hedge Fund 1.3166 302731 -5997 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.311 301436 36821 2022-12-31 LOW
Invesco Advisers, Inc. Investment Advisor 1.1857 272628 -621 2022-12-31 LOW
Allspring Global Investments, LLC Investment Advisor/Hedge Fund 1.1309 260029 -80814 2022-12-31 LOW
Millennium Management LLC Hedge Fund 1.0858 249658 249658 2022-12-31 HIGH

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Medical Devices & Implants

2850 Frontier Drive
WARSAW
INDIANA 46582
US

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

73.22 Price
+0.550% 1D Chg, %
Biaya inap posisi Long -0.0162%
Biaya inap posisi short -0.0057%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

XRP/USD

0.54 Price
-2.500% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00441

BTC/USD

28,653.45 Price
+0.760% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

US100

12,863.10 Price
+0.250% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda